BamSEC and AlphaSense Join Forces
Learn More

BioMarin Pharmaceutical Inc.

NASDAQ: BMRN    
Share price (12/23/24): $66.27    
Market cap (12/23/24): $12.6 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 40 pages Amended and Restated Bylaws of Biomarin Pharmaceutical Inc. Amended and Restated: December 15, 2022
12/34/56
EX-3.1
from 8-K 38 pages Amended and Restated Bylaws of Biomarin Pharmaceutical Inc. Amended and Restated: December 15, 2020
12/34/56
EX-3.1
from 8-K 38 pages Amended and Restated Bylaws of Biomarin Pharmaceutical Inc. Amended and Restated: September 19, 2018
12/34/56
EX-3.2
from 10-Q 29 pages Amended and Restated Bylaws of Biomarin Pharmaceutical Inc., as Amended Amended and Restated: June 9, 2015 Last Amended: September 28, 2017
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Amended and Restated Bylaws of Biomarin Pharmaceutical Inc
12/34/56
EX-3.2
from 8-K 10 pages Restated Certificate of Incorporation of Biomarin Pharmaceutical Inc
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Biomarin Pharmaceutical Inc
12/34/56
EX-3.1
from 10-Q 58 pages Amended and Restated Certificate of Incorporation of Biomarin Pharmaceutical Inc
12/34/56
EX-3.1
from 8-K 28 pages Amended and Restated Bylaws of Biomarin Pharmaceutical Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Elimination of Certificate of Designation, Preferences and Rights of Biomarin Pharmaceutical Inc. Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware
12/34/56
EX-3.3
from 10-K 2 pages Certificate of Amendment to Amended and Restated Certificate of Incorporation of Biomarin Pharmaceutical Inc
12/34/56
EX-3.1
from 8-K 29 pages Amended and Restated Bylaws of Biomarin Pharmaceutical Inc
12/34/56
EX-3.3
from 10-K 28 pages Amended and Restated Bylaws of Biomarin Pharmaceutical Inc
12/34/56
EX-3.1
from 8-K 27 pages Amended and Restated Bylaws of Biomarin Pharmaceutical Inc
12/34/56
EX-3.2
from 8-K 3 pages Corrected Certificate of Amendment to Amended and Restated Certificate of Incorporation of Biomarin Pharmaceutical Inc. Pursuant to Section 103(f) of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 27 pages Amended and Restated Bylaws of Biomarin Pharmaceutical Inc
12/34/56
EX-3.(I)
from 8-K ~20 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.(I)
from 10-Q ~20 pages Form 10q Exhibit 3.1
12/34/56
EX-3.(II)
from 10-Q ~20 pages Exhibit 3.2 General Bylaws
12/34/56
EX-3
from 10-K ~20 pages Amendment and Restatement of the By-Laws
12/34/56